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Abstract
Transcriptomic studies routinely measure expression levels across numerous conditions. These datasets allow
identification of genes that are specifically expressed in a small number of conditions. However, there are currently
no statistically robust methods for identifying such genes. Here we present SpeCond, a method to detect
condition-specific genes that outperforms alternative approaches. We apply the method to a dataset of 32 human
tissues to determine 2,673 specifically expressed genes. An implementation of SpeCond is freely available as a
Bioconductor package at http://www.bioconductor.org/packages/release/bioc/html/SpeCond.html.
Background
Cells sharing the same genomic information are able to
express it in different ways to achieve cell-specific func-
tions or respond to different environmental changes.
Transcriptional regulation ist h ef i r s ts t e pa tw h i c ht h i s
specificity is determined, as it is the most basic level at
which gene expression is controlled. Recent surveys of
transcriptomic data across numerous cell types revealed
two broad categories of gene expression: ubiquitous; and
tissue- or cell-type-specific expression [1,2]. The first
category contains genes that are expressed in most tis-
sues at similar levels and they are thought to provide
core cellular functionality [3,4]. The second category
comprises genes with distinct expression in a few tissues
or conditions, which are likely to be important for defin-
ing cell-specific functions.
In datasets with only a few conditions, it is possible to
compare pairs of conditions using standard or moder-
ated t-tests [5-7]. However, this becomes impractical
with large datasets, as the number of pairwise compari-
sons increases exponentially with respect to the number
of conditions studied. An alternative method is the non-
standard ANOVA, which tests all possible groups of
samples against each other. However, this involves com-
putationally intensive dynamic programming and cannot
detect specificity in individual conditions. Moreover, the
method requires equal standard deviations between all
groups of conditions being compared: this cannot be
assumed as genes might have similar expression levels
in some conditions - and thus small standard deviations
- and more divergent expression levels in others. A
further alternative is the Tukey test, although this
method requires independence between groups of con-
ditions and a normal distribution of group means, cri-
teria that are often not met in microarray experiments.
Importantly, most of these and other methods assume
that expression values follow a single normal distribu-
tion. This assumption is generally not satisfied, which
means that methods do not model the data correctly
and therefore lead to false positive results [8].
An alternative to these approaches is a mixture
model-based procedure to model gene expression.
EMMIX-GENE [9] and EMMIX-FDR [10] are software
packages that apply this technique to cluster genes dis-
playing similar expression patterns. However, these
packages were not specifically developed to detect con-
dition-specific expression, and therefore cannot be read-
ily applied for this purpose on large datasets. Moreover,
the method is not implemented in commonly used ana-
lysis platforms such as Bioconductor, making it difficult
to integrate with additional analysis pipelines.
Two additional methods were recently developed with
the specific aim of identifying condition-specific gene
expression. First, a method called ROKU [11] imple-
ments Shannon’s information theory entropy followed
by an outlier detection method [12] to detect tissue spe-
cificity. This method is implemented in the Tissue Spe-
cific Genes Analysis (TSGA) R package [13]. It returns a
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expressed. Unfortunately, this method depends on a
pre-defined set of ubiquitously expressed genes to
model background expression levels - information that
is generally not available prior to analysis. Furthermore,
the TSGA method produces qualitative outputs - a gene
is classified as either condition-specific or not without
ranking genes or conditions - which makes the resulting
lists difficult to prioritize for further analysis. Second,
Vaquerizas et al. [2] previously used a propensity mea-
sure for a given gene to be expressed at a certain level
in particular conditions relative to its expression across
other conditions. The method provides a ranking of
condition-specificity across samples. However, there is
no control over the number of conditions in which a
gene can be specific and there is no statistically mean-
ingful threshold for specificity. Therefore, to our knowl-
edge there is currently no straightforward and
statistically robust method available to detect condition-
specific gene expression.
Here we present a new method called SpeCond (for
Specific Condition) to detect condition-specificity from
a dataset of gene expression measurements. The method
fits a normal mixture model to the expression profile of
each gene, and identifies outlier conditions. We compare
SpeCond against several alternative approaches using a
gold standard dataset and demonstrate that SpeCond
outperforms other methods. Finally, we apply the Spe-
Cond approach to a subset of the Genome Novartis
Foundation SymAtlas dataset [14], and identify specifi-
cally expressed genes from 32 human tissues samples.
The method is freely available as an R package within
the Bioconductor software project [15-17] at [18].
Results
SpeCond in a nutshell
Briefly, SpeCond examines the distribution of expression
values for each gene in turn and then identifies outliers
that indicate unusually high or low expression in specific
conditions relative to others. It defines the background
distribution for a gene across conditions using a normal
mixture model. P-values are then calculated for the
expression values of the gene across all conditions using
the background distribution. After repeating the proce-
dure for every gene in the dataset, SpeCond corrects all
P-values for multiple testing. Finally, the method identi-
fies condition-specific expression values for each gene
using a P-value threshold (Figure 1). The different steps
implemented in the method are described in detail
below.
Modeling the null distribution
Previous methods have modeled gene-expression values
using a Gaussian distribution. However, most datasets
do not fit this distribution well, as they often exhibit
varying degrees of skewness [8]. To overcome this, we
use a mixture model that fits between one and three
normal distributions to the expression profile of a given
gene (Figure 1c). This is achieved using the mclust
package [19-21] in the R software environment [16,15].
The algorithm performs a hierarchical clustering of a
mixture model of normal distributions via expectation-
maximization. The best-fitting model is then selected
using the Bayesian information criterium.
In order to define the null distribution of a given gene
(Figure 1d), we identify and exclude the mixture compo-
nent(s) corresponding to outliers. First, we test whether
the mixture component has a median value distinct
enough from the median of the main component (test
performed using the md parameter). If this is true, we
then evaluate the following two possible scenarios (Fig-
ure 2): (i) whether the mixture component represents a
small proportion of the data and is well separated from
the main component; and (ii) whether the mixture com-
ponent represents a small proportion of the data and
has a large standard deviation compared with the main
component. Mixture components that satisfy either of
these criteria are likely to contain specific expression
values and will therefore be excluded from the null dis-
tribution. Once all mixture components have been eval-
uated, the remaining components are combined using
their means, standard deviations and relative weights. By
d e f a u l t ,i fo n l yas i n g l ec o m p o n e n tf i t st h ed a t a ,i t s
mean and standard deviation is used for the null distri-
bution. As a result, our approach returns the optimal
model for expression values after the identification of
outliers.
Identifying condition-specific expression values
Next, SpeCond computes a P-value for every expression
value to determine whether a gene is specifically
expressed. These P-values are based on the null distri-
bution of each gene, and are computed as the sum of
the P-values obtained from each mixture component,
weighted by the proportion of the component in the
mixture model. This procedure is applied to each gene
in turn, and the overall set of P-values is corrected for
multiple testing (Benjamini and Yekutieli method [22]).
Finally, a gene is determined to be specific if at least
one adjusted P-value is below the specified threshold
(pv parameter set to 0.05 by default). As a result, Spe-
Cond classifies each gene as either displaying specific
expression or not and returns the list of condition(s) in
which it is specific (Figure 1e).
User-defined parameters
SpeCond’s behavior is determined by a set of user-
defined parameters. These can be classified into three
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Figure 1 SpeCond workflow. (a-e) From a gene expression microarray dataset (a), for every gene (b), SpeCond uses a model of mixture of
normal distributions (c) to determine the null distribution (d) and identifies the condition(s) in which the gene presents a statistically significant
specific expression (e).
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Figure 2 Determination of the null distribution. Three different conditions are evaluated in order to consider a normal component as part of
the null distribution. (I) The median of the values from each component must have a difference larger than md. If this first condition is fulfilled,
the procedure tests the following conditions. The normal component will not be part of the null distribution if: (II) the normal component is
small and well separated, that is, the minimum of the absolute log-likelihood ratio of the expression values under the two components is larger
than mlk; or (III) the normal component is small and largely spread out, that is, the standard deviation ratio is smaller than rsd.
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normal mixture model (l and b); (ii) those used to
decide which normal distributions are included in the
f i n a ln u l ld i s t r i b u t i o n( md, per, mlk and rsd); and (iii) a
P-value threshold to define a gene as being condition-
specific (pv). A more detailed description of the para-
meters, including our choice for the default parameters,
is given in Additional file 1.
Comparison with other approaches
We chose the Genomics Institute of the Novartis
Research Foundation (GNF) dataset [14] to evaluate the
performance of our method. This dataset contains gen-
ome-wide expression profiles for 79 human tissues and
cell lines. To avoid redundancy of tissue types within
the dataset, we focused on 32 major healthy tissues and
organs present in the dataset (Table 1). We first pro-
cessed the data and determined the log2 expression
level for each probe set in each condition as described
in Additional file 1. We then applied SpeCond and two
other alternative approaches, namely TSGA and the
propensity method, to retrieve tissue-specific gene sets
(see Additional file 1 for the choice of parameters).
Using positive and negative gold standard sets con-
taining previously defined specifically and ubiquitously
expressed genes, respectively (Additional file 1), we
computed receiver operating characteristic (ROC) curves
to compare the performance of the three methods (Fig-
ure 3). Considering a 5% error rate, SpeCond achieved
the best sensitivity of all methods (62%; Figure 3a).
TSGA also showed good performance (60%), whereas
the propensity method had lower sensitivity (55%).
We also performed a Gene Ontology (GO) enrich-
ment analysis using the g:Profiler web-tool [23] and
computed overall log-scores to compare the perfor-
mance of each method from a biological perspective
(Additional file 1). SpeCond and TSGA showed similar
enrichment levels, outperforming the propensity method
(log-scores = 18,316, 17,664, and 15,629 for SpeCond,
TSGA and the propensity method, respectively). There-
fore, overall, SpeCond displays better sensitivity and spe-
cificity than either of the other available methods.
Detecting tissue specificity across the human genome
T od e m o n s t r a t et h eu s eo fo u rm e t h o d ,w ee x a m i n e d
the tissue-specific gene set returned by SpeCond when
applied to the GNF dataset. We identified 2,673 genes
as specific using the combination of parameters that
achieved the best sensitivity at a 5% false positive rate
(Additional file 2). Of these, 1,133 genes were detected
in only one tissue and 1,540 genes were specifically
expressed among several tissues (up to a maximum of 9
tissues). Figure 4 depicts a heatmap of tissue-specificity
profiles for these genes. The large majority
(approximately 99%) of genes that were specific were
due to an up-regulation in a few tissues; interestingly,
however, we also detected some genes that are specifi-
cally down-regulated compared to other tissues.
To assess the biological significance of the results
obtained with SpeCond, we performed a GO enrichment
analysis for each set of tissue-specific genes. For 28 out
of the 32 analyzed tissues, we observed many expected
molecular functions and pathways. For example, the GO
terms ‘contractile fiber’ and ‘heart morphogenesis’ are
enriched in heart, ‘spermatogenesis’ is specifically
enriched in testis, and ‘T cell activation’ is enriched in
the thymus. The remaining four tissues show a smaller
number of specific genes, which did not allow the iden-
tification of significantly enriched functions among the
specific genes.
Table 1 Numbers of tissue-specific genes for 32 human
tissues
Number of tissue-specific genes
Tissue Up-regulated Down-regulated Total
Whole brain 511 4 515
Whole blood 440 9 449
Testis 436 1 437
Fetal brain 406 4 410
Placenta 354 4 358
Liver 287 4 291
Skeletal muscle 279 16 295
Lung 278 1 279
Spinal cord 266 0 266
Fetal liver 261 0 261
Fetal lung 258 1 259
Thymus 249 0 249
Thyroid 244 1 245
Prostate 236 2 238
Smooth muscle 229 4 233
Heart 228 5 233
Bone marrow 227 0 227
Kidney 208 0 208
Uterus 199 1 200
Lymph node 194 1 195
Tonsil 179 0 179
Appendix 171 4 175
Pituitary 165 1 166
Trachea 162 0 162
Tongue 160 0 160
Pancreas 148 0 148
Skin 136 2 138
Adrenal gland 120 0 120
Fetal thyroid 119 1 120
Salivary gland 115 1 116
Adrenal cortex 85 0 85
Ovary 76 0 76
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Page 5 of 12Closer examination of the 287 liver-specific genes
detected by SpeCond showed many genes that are impor-
tant for liver functions, such as amino acid and fatty acid
metabolic processes or gluconeogenesis. Among them are
genes previously known to have liver-specific expression,
such as NR1I3, a key regulator of xenobiotic and endobio-
tic metabolism [24], and INSIG1,w h i c ht a k e sp a r ti n
metabolic control [25]. In addition, we found genes that
had not been originally assigned to have a liver-specific
function. One example is ATF5, which is implicated in dif-
ferentiation, proliferation and survival in different cell
types but whose function in liver had not been annotated.
The first indication of its function as a regulator of the
hepatic stress response was recently published [26].
Another example is illustrated by the central nervous
system. The brain, fetal brain and spinal cord present
(a)
(b) (c)
ROC curve
ROC curve - SpeCond method ROC curve - TSGA method
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Figure 3 Evaluation of the performance of the three methods. (a) SpeCond (blue), TSGA (purple), propensity method (cyan). (b,c) Detailed
parameter evaluation for the SpeCond and TSGA methods. (b) SpeCond: varying mlk (0 to 300) and rsd (0 to 2) parameters for the two steps
with b = 6 and 0 and per = 0.1 and (0.2, 0.3, 0.5) for step 1 and step 2, respectively. The red line represents optimal parameter set for each false
positive (FP) rate. (c) TSGA for the maximum number of specific tissue that can be detected N = 1, 2, 3, 4, 8, 11, 16, varying the H.critical value
from 1 to 19.8. TP: true positive.
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Page 6 of 12the largest list of tissue-specific genes (511 for brain,
406 for fetal brain and 266 for spinal cord; Table 1) and
share 144 specific genes showing neural-related specific
expression patterns. Functional profiling of tissue-speci-
fic genes shared by the three tissues revealed well-
known nervous-tissue functions such as ‘generation of
neuron’, ‘axonogenesis’,a n d‘synaptic transmission’,a s
well as the neural cellular component ‘neurofilament
cytoskeleton’.I na d d i t i o n ,w ew e r ea b l et oi d e n t i f y
EAAT1 (Excitatory amino acid transporter 1) as specific
in the three tissues outlined above. This gene is known
as a member of a family of high-affinity sodium-depen-
dent transporter molecules that regulate neurotransmit-
ter concentrations at the excitatory glutamatergic
synapses of the mammalian central nervous system [27].
Further, we detected many genes with expression
profiles specific for these tissues that have not been
experimentally associated with any neural function in
small-scale studies. Among these we found ZNF365 and
ZNF536, two transcription factors previously reported to
have brain- and spinal cord-specific expression [2].
Bioconductor R package
In order to provide easy access to the method, we devel-
oped SpeCond as an R package integrated within the
Bioconductor software (freely available from [18]). The
input to the software package is a matrix of normalized
expression values in which rows correspond to genes or
probe sets, and columns correspond to different condi-
tions. The package returns different outputs: (i) R
objects, (ii) text files that can be used for further analy-
sis, and (iii) HTML pages. A general HTML results page
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Figure 4 Heatmap representation of the tissue specificity of each gene. The specific behavior of every specific gene (y-axis) in every tissue
(x-axis) is represented by a colored box: blue if the gene is specifically up-regulated in the tissue, red if the gene is specifically down-regulated
in the tissue, and light grey if the gene does not present any specific expression for the tissue.
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Page 7 of 12Figure 5 SpeCond general HTML output (part 1). The HTML page displays a set of tables and figures: the parameters used in the analysis
(first table), the number of genes detected as specific in different numbers of conditions (first figure and second table), and the numbers of
specific genes (up-regulated, down-regulated and total) detected in each condition (second figure).
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Figure 6 SpeCond general HTML output (part 2). Following the tables and figures presented in Figure 5, the SpeCond general HTML page
presents a heatmap of the tissue-specific genes (third figure) followed by a table containing all the tissue-specific genes with the numbers and
tissues in which they are detected (up and down are separated). Links to an individual SpeCond specific HTML page, such as shown in Figure 7,
are present in the rightmost column of the table if the pages have been previously generated by the user.
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Page 9 of 12Figure 7 Individual SpeCond specific HTML page; output for a specific probe set. Example of the 1598_g_at probe set detected as specific
in six tissues. The HTML page displays the probe set (or gene) name and a set of tables and figures: the parameters used in the analysis (top
table), the expression profile (first figure), and the density curves of the mixture model fitting the expression values (normals 1, 2 and 3, in blue,
green and yellow, respectively), as well as the null distribution (red) (second figure). The parameters of each normal distribution as well as the
SpeCond parameter values are presented in the table below the second figure. Finally, the tissues in which the gene is detected as specific with
their corresponding adjusted P-value are presented in the bottom table.
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vior for the entire dataset (Figures 5 and 6). Further-
more, an individual results page can also be generated
for each gene (Figure 7; Additional file 3). The page dis-
plays an extensive set of figures illustrating the SpeCond
analysis performed. Thanks to a large set of visualization
functions for the results provided, the user can easily
test different configurations of the parameters to evalu-
ate which combination correctly corresponds to their
particular dataset.
Discussion
The widespread use of microarrays in biological research
over the past few years has generated a flood of data
characterizing gene expression across many tissues in
different species [28]. Determining tissue- or condition-
specific expression from these datasets is an important
aspect of genomic analysis. Indeed, genes with a particu-
larly high expression level in few conditions are likely to
be involved in cell-specific functions; therefore, such
genes could represent good candidates for tissue mar-
kers or drug targets. However, this detection is difficult
to perform using traditional statistical techniques and
few other methods were available.
Here we present SpeCond, a new statistical method to
detect condition-specific expression from microarray
data. We show that SpeCond is able to detect reliable
tissue-specific genes and we evaluated its performance
against alternative approaches. In all cases, SpeCond dis-
played higher sensitivity and a lower false discovery rate.
Importantly, the SpeCond package is not a black box;
the user is encouraged to test different parameter sets
to find the best sets returning meaningful results
according to relevant biological questions. Indeed, the
large set of visualization tools allows the user to exam-
ine expression patterns in detail, to verify the fitting of
the normal mixture distribution, as well as to easily
compare the overall specific gene sets resulting from the
use of different sets of parameters. In addition, the
selection of inputted conditions can alter the results
outputted by SpeCond; therefore, the user might con-
sider applying standard clustering methods to identify
the global variability in expression patterns among the
different conditions, before manually selecting the most
relevant conditions for the analysis.
A further advantage of SpeCond is its ability to gener-
ate ranked lists of genes based on their tissue-specific
expression. The ability to classify genes in regard to
their contribution to tissue-specificity should be helpful
to experimentalists that wish to identify candidate genes
for detailed follow-up studies. In addition, these ranked
lists can be used in computational approaches, such as
the examination of the organization of tissue-specific
transcriptional networks or the putative annotation of
unknown gene functions based on their expression
pattern.
In the future, it will be very interesting to analyze
RNA-seq data with the same purpose. However, the
model will need to be modified, since a normal distribu-
tion-based model would not be the best to fit sequen-
cing data. A negative binomial distribution as used in
the DESeq method [29] is certainly more appropriate,
and therefore a mixture of negative binomial distribu-
tion model would need to be created.
Conclusions
SpeCond is a new statistical method to detect condition-
specific expression from microarray data. SpeCond does
not impose a single normal distribution to estimate the
underlying distribution but computes an estimate of the
null distribution using a normal mixture model. Spe-
Cond is an ideal choice when no previous data about
the organization of the system under study are available,
as it is not assumed that the measured expression values
follow a single normal distribution. Finally, SpeCond is
immediately applicable to many datasets measuring gene
expression, including the detection of tissue-specific
alternative splicing, in any species.
Additional material
Additional file 1: Supplementary material. The document file contains
further information about data processing (ROC curve, GO analysis).
Additionally, we provide a more detailed description of the SpeCond
parameters.
Additional file 2: Table of human tissue-specific genes. The table lists
the 2,673 human genes detected as specific. For each of the 32 tissues
(column) the gene has a value of 1 if detected as specifically expressed,
-1 if detected as specifically repressed or 0 if it does not present specific
expression in the tissue.
Additional file 3: Individual SpeCond specific HTML page; output
for a specific probe set. Example of the 121_at probe set detected as
specific in two tissues. The HTML page displays the probe set (or gene)
name and a set of tables and figures: the parameters used in the analysis
(top table), the expression profile (first figure), and the density curves of
the mixture model fitting the expression values (normals 1, 2 and 3, in
blue, green and yellow, respectively), as well as the null distribution (red)
(second figure). The parameters of each normal distribution as well as
the SpeCond parameter values are presented in the table below the
second figure. Finally, the tissues in which the gene is detected as
specific with their corresponding adjusted P-value are presented in the
bottom table.
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Page 11 of 12At the proofs stage, a couple of publications have come to light that may
be useful for readers. These include the following work [30,31]. The authors
developed a method taking advantage of the large amount of publicly
available microarray datasets to identify silenced and expressed genes. The
use of a large amount of samples allows this method to take into account
the batch effect and so classify accurately the expression of genes in each
condition. This resource is
very useful as it provides transcription profiles of hundreds of cell types in
both humans and mouse, including both ubiquitous and condition-specific
genes.
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